Cargando…
Differential effects of wake promoting drug modafinil in aversive learning paradigms
Modafinil (MO) an inhibitor of the dopamine transporter was initially approved to treat narcolepsy, a sleep related disorder in humans. One interesting “side-effect” of this drug, which emerged from preclinical and clinical studies, is the facilitation of cognitive performance. So far, this was prim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541287/ https://www.ncbi.nlm.nih.gov/pubmed/26347629 http://dx.doi.org/10.3389/fnbeh.2015.00220 |